Newlink Genetics reported $86.76M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Capricor Therapeutics CAPR:US $ 58.33M 23.45M
Celldex Therapeutics CLDX:US $ 25.29M 13.85M
Intrexon XON:US $ 41.73M 5.32M
Nektar Therapeutics NKTR:US $ 25.22M 28.8M
Newlink Genetics NLNK:US $ 86.76M 8.05M
Prothena PRTA:US $ 542.99M 36.1M